Cite
Bayoglu İV, Yildiz I, Varol U, et al. Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study. Contemp Oncol (Pozn). 2015;19(5):385-90doi: 10.5114/wo.2015.53374.
Bayoglu, �. �. V., Yildiz, I., Varol, U., Cokmert, S., Alacacıoğlu, A., Kucukzeybek, Y., Akyol, M., Demir, L., Dirican, A., & Tarhan, O. (2015). Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study. Contemporary oncology (Poznan, Poland), 19(5), 385-90. https://doi.org/10.5114/wo.2015.53374
Bayoglu, İbrahim V, et al. "Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study." Contemporary oncology (Poznan, Poland) vol. 19,5 (2015): 385-90. doi: https://doi.org/10.5114/wo.2015.53374
Bayoglu İV, Yildiz I, Varol U, Cokmert S, Alacacıoğlu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Tarhan O. Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study. Contemp Oncol (Pozn). 2015;19(5):385-90. doi: 10.5114/wo.2015.53374. Epub 2015 Aug 13. PMID: 26793023; PMCID: PMC4709396.
Copy
Download .nbib